Aluari Gomecii Eulaliensis Edyllia aliquot, siue Poematia.

Signaturas: A-E\p8\s

Chronic lead intoxication and growth and cognitive-emotional development in children

Objetivo: Determinar la asociación entre intoxicación plúmbica crónica y alteraciones del crecimiento y desarrollo cognitivo-emocional en niños del colegio “María Reiche”- Callao. Diseño: Estudio observacional de corte transversal. Material y métodos: A 70 niños de 8 a 12 años de edad del C.E. Nº 5045 “María Reiche” del A.A.H.H. “Puerto Nuevo”- Callao, que participaron en el estudio de dosaje de plomo en sangre hecho por la Dirección General de Salud Ambiental en 1999, se les aplicó pruebas de seguimiento de instrucciones, habilidades motoras, comunicativas, manipulativas, académicas y la lista de chequeo de ansiedad. Se midió el coeficiente intelectual e índice de masa corporal. Para el procesamiento de los datos se empleó las pruebas chi-cuadrado, t de Student, correlación y regresión lineal simple, usando el paquete estadístico SPSS versión 11.0, con un nivel de confianza de 95%. Resultados: Los niveles de plomo en sangre y los grados de ansiedad se relacionaron significativamente mediante la prueba chi-cuadrado (p=0,025); se encontró diferencias significativas entre las medias del puntaje de la lista de chequeo de ansiedad y la categorización de los niveles de plomo, mediante la prueba t de Student (p= 0,031). La relación entre los niveles de plomo en sangre y el coeficiente intelectual, las habilidades académicas, motoras, comunicativas, manipulativas, seguimiento de instrucciones e índice de masa corporal no resultaron significativos. Concluisones: Se encontró asociación significativa entre la intoxicación plúmbica crónica y el grado de ansiedad (desarrollo emocional). Sin embargo, no se encontró asociación con el crecimiento ni con el desarrollo cognitivo.Objetive: To determine the association between chronic lead intoxication and growth and cognitiveemotional development alterations in children at “María Reiche” school - Callao. Design: Crossectional study. Material and methods: To 70 children 8 to 12 year-old from “María Reiche” school (A.A.H.H. “Puerto Nuevo”- Callao), who had participated in a survey blood lead screening (General Direction of Environmental Health, in 1999), we applied instructions monitoring tests, communicative, motor, manipulator, and academic abilities test as well as anxiety checkup list. The intellectual coefficient and BMI (body mass index) were measured. Chi square, t-Student and simple lineal correlation tests were employed for prosecution of data using the statistical package SPSS version 11.0 with a 95% confidence level. RESULTS: By chi square test there was a significant (p=0,025) relation between blood lead levels and degrees of anxiety. There was significant difference between anxiety check-up list score averages and categorization of lead levels by t-Student test (p=0,031). The relation between blood lead levels and intellectual coefficient, as well as communicative, motor, academic, manipulator abilities, monitoring of instructions and body mass index did not turn out to be significant. Conclusion: There is an association between chronic lead intoxication and anxiety degree (emotional development). However, there was no association with growth or cognitive development

The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis

Background: premorbid IQ (pIQ) and age of onset are predictors of clinical severity and long-term functioning after a first episode of psychosis. However, the additive influence of these variables on clinical, functional, and recovery rates outcomes is largely unknown. Methods: we characterized 255 individuals who have experienced a first episode of psychosis in four a priori defined subgroups based on pIQ (low pIQ < 85; average pIQ ≥ 85) and age of onset (early onset < 18 years; adult onset ≥ 18 years). We conducted clinical and functional assessments at baseline and at two-year follow-up. We calculated symptom remission and recovery rates using the Positive and Negative Symptoms of Schizophrenia Schedule (PANSS) and the Global Assessment Functioning (GAF or Children-GAF). We examined clinical and functional changes with pair-wise comparisons and two-way mixed ANOVA. We built hierarchical lineal and logistic regression models to estimate the predictive value of the independent variables over functioning or recovery rates. Results: early-onset patients had more severe positive symptoms and poorer functioning than adult-onset patients. At two-year follow-up, only early-onset with low pIQ and adult-onset with average pIQ subgroups differed consistently, with the former having more negative symptoms (d = 0.59), poorer functioning (d = 0.82), lower remission (61% vs. 81.1%), and clinical recovery (34.1% vs. 62.2%). Conclusions: early-onset individuals with low pIQ may present persistent negative symptoms, lower functioning, and less recovery likelihood at two-year follow-up. Intensive cognitive and functional programs for these individuals merit testing to improve long-term recovery rates in this subgroup

Treatment variability and its relationships to outcomes among patients with Wernicke's encephalopathy: A multicenter retrospective study

Background: Despite guidelines and recommendations, Wernicke's encephalopathy (WE) treatment lacks evidence, leading to clinical practice variability.Aims: Given the overall lack of information on thiamine use for WE treatment, we analyzed data from a large, well-characterized multicenter sample of patients with WE, examining thiamine dosages; factors associated with the use of different doses, frequencies, and routes; and the influence of differences in thiamine treatment on the outcome.Methods: This retrospective study was conducted with data from 443 patients from 21 centers obtained from a nationwide registry of the Spanish Society of Internal Medicine (from 2000 to 2012). Discharge codes and Caine criteria were applied for WE diagnosis, and treatment-related (thiamine dosage, frequency, and route of administration) demographic, clinical, and outcome variables were analyzed.Results: We found marked variability in WE treatment and a low rate of high-dose intravenous thiamine administration. Seventy-eight patients out of 373 (20.9%) received > 300 mg/day of thiamine as initial dose. Patients fulfilling the Caine criteria or presenting with the classic WE triad more frequently received parenteral treatment. Delayed diagnosis (after 24 h hospitalization), the fulfillment of more than two Caine criteria at diagnosis, mental status alterations, and folic acid deficiency were associated significantly with the lack of complete recovery. Malnutrition, reduced consciousness, folic acid deficiency, and the lack of timely thiamine treatment were risk factors for mortality.Conclusions: Our results clearly show extreme variability in thiamine dosages and routes used in the management of WE. Measures should be implemented to ensure adherence to current guidelines and to correct potential nutritional deficits in patients with alcohol use disorders or other risk factors for WE

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

[Abstract] Background and Aims. Hepatitis C (HCV) therapy with Sofosbuvir (SOF)/Simeprevir (SMV) in clinical trials and real‐world clinical practice, showed high rates of sustained virological response (SVR) in non‐cirrhotic genotype (GT)‐1 and GT‐4 patients. These results were slightly lower in cirrhotic patients. We investigated real‐life effectiveness and safety of SOF/SMV with or without ribavirin (RBV) in a large cohort of cirrhotic patients. Methods. This collaborative multicentre study included data from 968 patients with cirrhosis infected with HCV‐GT1 or 4, treated with SOF/SMV±RBV in 30 centres across Spain between January‐2014 and December‐2015. Demographic, clinical, virological and safety data were analysed. Results. Overall SVR was 92.3%; the majority of patients were treated with RBV (62%) for 12 weeks (92.4%). No significant differences in SVR were observed between genotypes (GT1a:94.3%; GT1b:91.7%; GT4:91.1%). Those patients with more advanced liver disease (Child B/C, MELD≥10) or portal hypertension (platelet count≤100×109/L, transient elastography≥21 Kpa) showed significantly lower SVR rates (84.4%‐91.9%) than patients with less advanced liver disease (93.8%‐95.9%, P<.01 in all cases). In the multivariate analysis, the use of RBV, female gender, baseline albumin≥35 g/L, MELD<10 and lack of exposure to a triple therapy regimen were independent predictors of SVR (P<.05). Serious adverse events (SAEs) and SAE‐associated discontinuation events occurred in 5.9% and 2.6%. Conclusions. In this large cohort of cirrhotic patients managed in the real‐world setting in Spain, SOF/SMV±RBV yielded to excellent SVR rates, especially in patients with compensated liver cirrhosis. In addition, this combination showed to be safe, with low rates of SAEs and early discontinuations.Instituto de Salud Carlos III; PI15/0015

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study

Poster presentatio

Integral care guide for early detection and diagnosis of depressive episodes and recurrent depressive disorder in adults. Integral attention of adults with a diagnosis of depressive episodes and recurrent depressive disorder part II : general aspects of treatment, management of the acute phase, continuation and maintenance of patients with a depression diagnosis

Introducción El presente artículo busca presentar las recomendaciones basadas en la evidencia que surgieron como respuesta a una serie de preguntas clínicas respecto al episodio depresivo y al trastorno depresivo recurrente, haciendo hincapié en los aspectos generales de tratamiento, el tratamiento en la fase aguda y el manejo de la fase de continuación/mantenimiento, con el fin de brindar parámetros de atención en salud basados en la mejor y más actualizada evidencia disponible para lograr los estándares mínimos de calidad en el abordaje de adultos con dichos diagnósticos. Método Se elaboró una guía de práctica clínica bajo los lineamientos de la Guía Metodológica del Ministerio de la Protección Social. Se adaptaron las recomendaciones de las guías NICE90 y CANMAT para las preguntas que estas guías contestaban y se desarrollaron de novo para las preguntas no encontradas. Resultados Se presentan las recomendaciones 5-22 correspondientes al manejo de la depresión.Q4740-773Introduction This article presents recommendations based on evidence gathered to answer a series of clinical questions concerning the depressive episode and the recurrent depressive disorder, with emphasis on general treatment aspects, treatment in the acute phase and management of the continuation/maintenance, all intended to grant health care parameters based on the best and more updated available evidence for achieving minimum quality standards with adult patients thus diagnosed. Methodology A practical clinical guide was elaborated according to standards of the Methodological Guide of the Ministry of Social Protection. Recommendation from NICE90 and CANMAT guides were adopted and updated so as to answer the questions posed while de novo questions were developed. Results Recommendations 5-22 corresponding to management of depression are presented

BIOVID: Micro espacios audiovisuales sobre biodiversidad

Se han realizado, editado y publicado microespacios de video alojados en la web www.ucm.es/segbiodiversidad/videos sobre aspectos relacionados con la biodiversidad, ecología y metodologías de seguimiento de aves, murciélagos, artrópodos y flora del campus de la Universidad Complutense de Madrid